Fundraising Fox
Evoendo
Centennial, US · Founded 2017 · United States corporation · 19 employees on LinkedIn · 1 known investors
Find your way into Evoendo
Sign up to see every warm intro you have to Evoendo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Evoendo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EvoEndo makes an FDA-cleared endoscopy system for sedation-free transnasal and traditional transoral procedures in adult and pediatric patients. Its offering combines a single-use ultra-slim flexible gastroscope with four-way steering, a portable controller, and a virtual reality-based patient distraction system, aimed at gastroenterologists treating conditions such as eosinophilic esophagitis.
Founders & leadership
Evoendo was founded in 2017 by Joel Friedlander, Emily DeBoer, Robin Deterding, and Jeremy Prager.
ED
Emily DeBoerCo-Founder
RD
Robin DeterdingCo-FounderRobin Deterding is a pediatric pulmonologist and Professor of Pediatrics at the University of Colorado School of Medicine, where she serves as Chief of Pediatric Pulmonary and Sleep Medicine and Medical Director of the Breathing Institute at Children's Hospital Colorado. She co-founded EvoEndo and has held leadership roles including Associate Dean of the Clinical Curriculum and Director of Innovation at Children's Hospital Colorado.
JP
Jeremy PragerCo-Founder
JH
Jonathan HartmannChief Executive OfficerJonathan Hartmann is a healthcare executive with over 25 years of experience in the medical device industry, holding roles spanning general management, sales, marketing, and business development. He holds a B.S. from St. Lawrence University and an MBA from Harvard Business School, and currently serves as President and CEO of EvoEndo.
RH
Ryan HartmanChief Operating OfficerRyan Hartman is the Executive Officer of EvoEndo, which makes an FDA-cleared endoscopy system for sedation-free procedures.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 3 rounds · 2018–2024
▶$2.3MraisedAug 2024 · 4 investors · Other Health CareRule 506(b)
▶$2.3MraisedAug 2024 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Betsy LahueDirector
- David BunningDirector
- Chris RowlandDirector
- Jeff HarringtonDirector
- Joel FriedlanderExecutive Officer, Director
- Jonathan HartmannExecutive Officer, Director
- Carl TraynorDirector
- David PierceDirector
- Ryan HartmanExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Aug 2024
- Incorporated
- Corporation, United States
- Federal exemptions
- 06b
▶$1.9MraisedDec 2019 · 5 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2019 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff HarringtonDirector
- Jeremy PragerDirector
- Robin DeterdingExecutive Officer, Director
- Joel FriedlanderExecutive Officer, Director
- Emily DeBoerDirector
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KraisedMar 2018 · 3 investors · Other Health CareRule 506(b)
▶$500KraisedMar 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Emily DeBoerDirector
- Robin DeterdingExecutive Officer, Director
- Jeremy PragerDirector
- Joel FriedlanderExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- Proceeds to insiders
- $2.7K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
OlympusamericaOlympus develops medical technologies and solutions for detecting and treating disease. The company serves healthcare systems, patients, and medical professionals globally.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Integrated EndoscopyiEscope manufactures single-use surgical arthroscopes for orthopedic procedures, offering sterile, pre-assembled optical instruments that eliminate traditional sterilization and maintenance costs. The company serves surgical centers and hospitals seeking reliable backup instrumentation with consistent image quality across all operating room settings.
Companies working in the same space as Evoendo.
Frequently asked questions
- What does Evoendo do?
- EvoEndo makes an FDA-cleared endoscopy system for sedation-free transnasal and traditional transoral procedures in adult and pediatric patients. Its offering combines a single-use ultra-slim flexible gastroscope with four-way steering, a portable controller, and a virtual reality-based patient distraction system, aimed at gastroenterologists treating conditions such as eosinophilic esophagitis.
- Who founded Evoendo?
- Evoendo was founded by Joel Friedlander, Emily DeBoer, Robin Deterding, Jeremy Prager in 2017.
- Who are Evoendo's investors?
- Evoendo's investors include Allerfund Ventures, Llc.
- How much funding has Evoendo raised?
- Evoendo has disclosed $4.7M raised across 3 rounds.
- Where is Evoendo headquartered?
- Evoendo is headquartered in Centennial, US.